Ambry Genetics at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Ambry Genetics brings 12 presentations to ASHG 2026 in Montréal, and exhibits at Booth 1201. Its program centres on rare-disease diagnosis, hereditary cancer, and computational approaches to clinical genetics at this meeting. Its presentations explore long-read sequencing with methylation analysis in the UCI-GREGoR rare disease cohort and RNA testing to clarify uncertain exome variants.

OrganizationASHG 2026 Attendance
Ambry Genetics
Aliso Viejo, California
2 Scientists · 1 Variant Assessment Scientist · 1 Bioinformatics Scientist and Engineer · 1 Genetic Counselor · 2 other presenters
Subsidiary
Clinical genetic testing laboratory serving healthcare providers with hereditary cancer, rare disease, and specialty genomic testing.
A study found Ambry's ExomeReveal RNA testing improves diagnostic clarity for uncertain exome variants, useful evidence for their pitch.
›
A study found Ambry's ExomeReveal RNA testing improves diagnostic clarity for uncertain exome variants, useful evidence for their pitch.
2026-06 · source
Ambry's CARE Program won a 2026 MedTech Breakthrough award for best overall health informatics solution.
2026-05 · source
Ambry's MAVE research is supporting thousands of patient variant reclassifications and expanding coverage to new genes.
2026-02 · source
Source: company newsroom
Booth
Exhibiting at Booth 1201
Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm
Poster
Wed Oct 21
2:30 pm
MAVE Progress Report, Clinical Implementation of High-Throughput Functional Assays
CancerGenetic testingRare variantsVariant interpretation
Poster
Wed Oct 21
2:30 pm
Optimizing clinical next-generation sequencing workflows through evidence-based expansion of statistical confirmation criteria
Exome/genome sequencingTargeted sequencingBioinformaticsClinical genetics
Poster
Wed Oct 21
2:30 pm
Evaluating Secondary Findings in Prenatal Exome Sequencing: A Study of Uptake and Yield for ACMG and Childhood Onset Disorder Results
Clinical geneticsClinical testingExome/genome sequencingGenetic counseling
Poster
Wed Oct 21
2:30 pm
The ATM Splice-ome: Charting the multifaceted splicing landscape of ATM
CancerDiagnosticsGene regulationSplicing mechanisms
Poster
Thu Oct 22
4:15 pm
★ Reviewers’ Choice
Concurrent Long-Read Genome Sequencing with Methylation Pattern Analysis Enhances Diagnostic Yields in the UCI-GREGoR Rare Disease Cohort
BioinformaticsComputational toolsDiagnosticsEpigenetics
Poster
Thu Oct 22
4:15 pm
★ Reviewers’ Choice
Piloting the Forthcoming ACMG/AMP/CAP/ClinGen Standards for Sequence Variant Classification
Collaborators: James Cook University, University of North Carolina at Chapel Hill +8 more
Clinical testingGenetic testingLaboratory genetics and genomicsVariant interpretation
Poster
Fri Oct 23
2:30 pm
Into the Abyss: Mapping the Landscape of Deep Intronic Pathogenicity
CancerVariant interpretationClinical geneticsLaboratory genetics and genomics

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Ambry Genetics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction